Gene · 6508
Papers3,779
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,779
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Undifferentiated Pancreatic Carcinomas, Clinical Features and Therapeutic Options: What We Know. | Cancers (Basel) | 2022 | 36551588 | PubTator, text mining | PubMed |
| Clinical and Histopathologic Profile of Patients with Cutaneous Metastasis in a Tertiary Hospital in the Philippines. | Dermatopathology (Basel) | 2022 | 36547220 | PubTator, text mining | PubMed |
| A case of undifferentiated carcinoma of the bladder treated by combination therapy of surgery, local radiation, and immune checkpoint inhibitors. | Nagoya J Med Sci | 2022 | 36544596 | PubTator, text mining | PubMed |
| High-Grade Mucinous Adenocarcinoma of the Appendix With Signet Features and Omental Metastasis. | Cureus | 2022 | 36532943 | PubTator, text mining | PubMed |
| Genome-wide characterization of the Triplophysa dalaica slc4 gene family and expression profiles in response to salinity changes. | BMC Genomics | 2022 | 36513970 | PubTator, text mining | PubMed |
| Cystic trophoblastic tumour of the testis: Case report. | Cesk Patol | 2022 | 36513508 | PubTator, text mining | PubMed |
| Rare renal cell carcinoma with haemangioblastoma-like features and leiomyomatous stroma: report of a unique case with TSC2 and SETD2 variations. | World J Surg Oncol | 2022 | 36510186 | PubTator, text mining | PubMed |
| Combination chemotherapy of doxorubicin and ifosfamide with proton beam therapy for myoepithelial carcinoma originating in the paraspinal region: A case report and literature review. | Mol Clin Oncol | 2022 | 36482942 | PubTator, text mining | PubMed |
| Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitis. | Commun Biol | 2022 | 36482174 | PubTator, text mining | PubMed |
| Case Report: The first case of primary pulmonary collision tumor comprising mixed squamous cell and glandular papilloma and glomus tumor. | Front Oncol | 2022 | 36479078 | PubTator, text mining | PubMed |
| Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errors. | EJHaem | 2022 | 36467796 | PubTator, text mining | PubMed |
| From Keratoma to Anaplastic Malignant Melanoma in a Horse's Hoof. | Animals (Basel) | 2022 | 36428318 | PubTator, text mining | PubMed |
| Thymic lipofibroadenoma of the anterior mediastinum: A rare case report. | Medicine (Baltimore) | 2022 | 36401401 | PubTator, text mining | PubMed |
| EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative. | Infect Agent Cancer | 2022 | 36397137 | PubTator, text mining | PubMed |
| Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis. | Am J Dermatopathol | 2022 | 36395448 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part II. | Rom J Morphol Embryol | 2022 | 36374135 | PubTator, text mining | PubMed |
| Genetics of congenital arrhythmia syndromes: the challenge of variant interpretation. | Curr Opin Genet Dev | 2022 | 36368182 | PubTator, text mining | PubMed |
| Generalization of Deep Learning in Digital Pathology: Experience in Breast Cancer Metastasis Detection. | Cancers (Basel) | 2022 | 36358842 | PubTator, text mining | PubMed |
| ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance. | Cancer Res | 2022 | 36353752 | PubTator, text mining | PubMed |
| Carcinoma of Unknown Original Identified as Renal Cell Carcinoma by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan: A Report of Two Cases. | Cureus | 2022 | 36337777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6508/papers?page=17